Biocon Biologics Archives - Express Pharma

Biocon Biologics, Yoshindo launch Ustekinumab biosimilar in Japan

Biocon Biologics gains market access coverage for Yesintek in the US

Biocon Biologics receives positive CHMP opinions for denosumab biosimilars Vevzuo and Denosumab BBL

Biocon Biologics signs US settlement with Regeneron to Launch Yesafili Biosimilar by 2026

Biocon Biologics secures US FDA approval for Biosimilar Bevacizumab, JOBEVNE

Biocon Biologics announces positive results from Phase 3 Study of Yesintek biosimilar to Ustekinumab for chronic plaque psoriasis

Biocon Biologics launches YESINTEK, a Stelara biosimilar, in the United States

Biocon’s S&P Global ESG Score improves to 69 for 2024

US FDA classifies Biocon Biologics site as VAI

Biocon Biologics completes one year as an integrated global biosimilars enterprise